# P15.02 Toripalimab and Platinum-Doublet Chemotherapy as Neoadjuvant Therapy for Potentially Resectable Non-Small Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/p15-02-toripalimab-and-platinum-doublet-chemotherapy-as-neoadjuvant-therapy-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Y. Zhang,L. Zeng,X. Zhang,Yujuan Zhou,Bei Zhang,Wenjuan Jiang,Nong Yang,Caicun Zhou |
| Citations | 5 |
| DOI | 10.1016/j.jtho.2021.08.339 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.jto.org/article/S1556086421027623/pdf |
| OpenAlex ID | https://openalex.org/W3205916391 |
| Type | conference-abstract |
| Year | 2021 |

## Paper authors

- [L. Zeng](https://scholariq.org/researchers/l-zeng/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

## Paper topics

- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.